NICE recommends Sogroya for growth hormone deficiency in children - PharmaTimes Treatment provides option for children with growth failure

#NICE #Sogroya #somapacitaninjection #growthhormonedeficiency #paediatricgrowthhormonedeficiency #NovoNordiskUK #growthfailure #growthhormone #hormonereplacement #endogenousgrowthhormone #NICErecommendation #growthhormonedeficiencies #adultgrowthhormonedeficiency
pharmatimes.com/news/nice-re...

Changes approved to the routing criteria for highly specialised technologies

#NICEnews #NICE #highlyspecialisedtechnologies #NICEevaluations #NICEdecisions #HSTprogramme #ultrararediseases #routing #NICEroutingcriteria #RareDiseasesActionPlan #rarediseases #costeffectivenessthreshold #NHS #NHSresources #NICErecommendation
www.nice.org.uk/news/article...

AstraZeneca receives positive recommendations for lung cancer treatments - PharmaTimes NICE endorses Imfinzi and Tagrisso for enhanced lung cancer care

#AstraZeneca #lungcancer #NICE #Imfinzi #durvalumab #Tagrisso #osimertinib #NICEpositiverecommendation #NICErecommendation #NHSEngland #NHSWales #ESSCLC #CASPIANPhaseIIItrial #overallsurvivalbenefits #ThoracicOncology #NSCLC #ADAURAphase3trial
pharmatimes.com/news/astraze...

Imfinzi receives NICE recommendation for lung cancer treatment - PharmaTimes Trial results lead to new treatment option for lung cancer

#oncology #Imfinzi #durvalumab #AstraZeneca #NICErecommendation #lungcancer #lungcancerpatients #lungcancertreatment #resectablenonsmallcelllungcancer #NSCLC #AEGEANphase3trial #NHS #NSCLCpatients #ThoracicOncology #patientoutcomes #AEGEANtrial
pharmatimes.com/news/imfinzi...

Outlook Therapeutics Receives NICE Recommendation of Lytenava for Wet AMD - Eyewire+ The UK’s National Institute for Health and Care Excellence (NICE) has recommended Lytenava (bevacizumab gamma) as an option for the tr

#OutlookTherapeutics #NICERecommendation #Lytenava #bevacizumabgamma #bevacizumab #WetAMD #ophthalmology #biopharmaceuticals #retinadisease #NICE #NICErecommended #VEGF #WetAMDpatients #NHSEngland #NHSWales #MHRA #NORSEONE #NORSETWO #NORSETHREE #clinicaltrials #Cencora
eyewire.news/news/outlook...